Has Vikas Patel, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,808 in general payments to Vikas Patel, MD across 22 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Vikas Patel, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Vikas Patel, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Vikas Patel, MD

Emergency Medicine · Arlington Heights, ILNPI 1598756348

Payments from drug & device makers

$1,808in general payments, 2019–2025

Across 22 payments — averaging $82.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$2K
Abbott$153
AstraZeneca$42
Portola Pharmaceuticals, LLC$33
Boston Scientific$30
AbbVie$18

What the payments were for

Travel & lodging$1,13863%
Food & beverage$67037%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(3 entities)	11	$1,532
Abbott	5	$153
AstraZeneca	2	$42
Portola Pharmaceuticals, LLC	2	$33
Boston Scientific	1	$30
AbbVie	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

CoreValve Evolut$1,138
COREVALVE EVOLUT R$107

How this compares

$1,808 in reported general payments places this provider in the 95th percentile of 2,434 emergency medicine providers in Illinois.

See all emergency medicine providers in Illinois →

Medicare billing

Part B allowed, 2024

$87,375

Medicare patients

505

Services billed

787

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Carvedilol	11	$342
Albuterol Sulfate HfaAlbuterol Sulfate	11	$316
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	63	$290
Cephalexin	36	$124
Ibuprofen	25	$89
Doxycycline Hyclate	11	$82
Ondansetron OdtOndansetron	27	$77
Prednisone	34	$46
Meclizine Hcl	12	$39
Naproxen	12	$37
Cyclobenzaprine Hcl	13	$30
Famotidine	12	$21

Paid to pharmacies, not to this prescriber.

Other emergency medicine in Arlington Heights

Erika ClaytonBolingbrook$837K
Kristen FergusonSpringfield$511K
Lois ClarkeChicago$415K
Michael GottliebChicago$364K
Jonathan ClaudLisle$171K
Christopher RossChicago$132K
Jonathan HandlerNorthbrook$113K
Erik KulstadChicago$109K
Philip MitchellNormal$107K
Adam GoodcoffChicago$98K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →